Work

Efficacy and Mechanisms Of The mTOR Inhibitor AZD2014 Combined With L-Asparaginase Or JAK2 Inhibitor TG101348 In ALL

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.1282.1282

Authors: Yoko Tabe, Linhua Jin, Hiroko Iwanami, Hiromichi Matsushita, Saiko Kazuno, Tsutomu Fujimura, Takashi Ueno, Takashi Miida, David M. Weinstock, Deborah A. Thomas, Michael Andreeff, Marina Konopleva

Institutions: The University of Texas MD Anderson Cancer Center, Juntendo University, Tokai University, Tokai University Hospital, Dana-Farber Cancer Institute

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1442691200

FWCI:

Cites:

Cited by: 2

Related to: 10